Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from the Annual Meeting of Shareholders held on May 19, 2026. The filing presents final voting tallies for two proposals: (1) election of six board members (Vince Crisler, John P. Gilliam, Emily Lu, Laura F. Shunk, Charles Wickersham, and Jeremiah R. Young), and (2) ratification of GBQ Partners LLC as the independent auditor. Board elections and auditor ratification are material governance matters that affect investor assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
Chubb agreed to sell $1 billion of Senior Notes due 2036 in a public offering, guaranteed by Chubb Limited. While this is a material debt issuance affecting the registrant's capital structure and financial position, it does not fit cleanly into the more specific event categories (e.g., it is not M&A activity, a covenant breach, or a dilutive equity issuance). The disclosure is material to investors as it represents a significant financing event, but the taxonomy lacks a dedicated debt issuance category, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of International Bancshares Corporation's 2026 Annual Meeting of Shareholders held on May 18, 2026. The filing presents detailed voting tallies for three proposals: election of eight directors, ratification of RSM US LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. All three proposals passed by majority vote, with specific vote counts provided for each director nominee and proposal.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 3.02
Stone Point Credit Income Fund disclosed an unregistered sale of 110,889.543 common shares at net asset value of $24.7599 for aggregate proceeds of $2,745,614, conducted pursuant to Section 4(a)(2) and Regulation D Rule 506. This is a classic dilutive private placement by a fund raising capital from accredited investors without public registration, directly matching the dilutive_issuance taxonomy.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 7.01
Royal Caribbean discloses that SEMARNAT (Mexican environmental authority) will deny approval of environmental permits for the "Perfect Day Mexico" project, a significant capital investment. While this is a regulatory setback rather than a traditional M&A termination, the denial of environmental permits for a major development project materially affects the company's growth strategy and capital allocation plans. The company's commitment to "re-engage stakeholders" suggests the project remains in flux, making this a material event that would affect investor assessment of the company's Mexico expansion prospects.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Epsilon Energy's 2026 Annual General Meeting held on May 20, 2026. The filing presents voting outcomes for five proposals: setting the board size at eight directors, electing eight directors (with individual vote tallies for each nominee), re-appointing BDO USA as auditors, a non-binding advisory vote on named executive officer compensation, and approval of the amended 2020 Equity Incentive Plan. All proposals passed with substantial majorities. This is material as shareholder votes on board composition, auditor appointment, and equity plans directly affect corporate governance and investor interests.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on May 19, 2026, covering three proposals: election of nine directors, advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. The filing directly corresponds to Item 5.07 and presents the vote tallies and approval percentages for each proposal, which is material to investors' understanding of corporate governance and stakeholder approval.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Principal Financial Group's annual meeting held May 19, 2026. The filing reports voting outcomes on four matters: election of Class I directors (five nominees), advisory vote on executive compensation, ratification of independent auditors, and approval of the 2026 Stock Incentive Plan. All matters passed with substantial majorities, making this a material governance event that investors rely upon to assess board composition and compensation oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Interlink Electronics' 2026 annual meeting of stockholders held on May 19, 2026. The filing presents detailed vote tallies for four proposals: election of four directors (Steven N. Bronson, Joy C. Hou, David J. Wolenski, and Maria N. Fregosi), advisory approval of executive compensation, ratification of LMHS, P.C. as independent auditor, and adoption of the 2026 Omnibus Incentive Plan. All proposals passed with substantial majorities, making this a material disclosure of shareholder voting outcomes.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-05-20
Item 1.01
Hudson Technologies entered into a material definitive agreement, specifically a Fifth Amendment to its revolving credit facility that increases the letter of credit sublimit from $1.5 million to $2.5 million. The amendment represents a routine modification to the company's existing credit arrangements.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-20
Item 5.02
William Davies, Executive Vice President and Global Chief Investment Officer, is retiring from Ameriprise Financial effective June 30, 2026. This departure of a senior named executive officer responsible for global investment strategy is material to investor assessment of the company's leadership and investment direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 72%
filed 2026-05-20
Item 1.01
The Company entered into a Debt Settlement and Subscription Agreement on May 14, 2026, to resolve a material default on a $700,000 revolving loan. The settlement involves both a cash payment of $800,000 and issuance of 71,482 shares of common stock valued at $232,315, representing a material restructuring of the Company's debt obligations. While this is primarily a debt settlement rather than a traditional M&A transaction, it constitutes a material definitive agreement that restructures the Company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-20
Item 5.02
The filing discloses shareholder approval of the 2026 Long-Term Incentive Plan, which authorizes awards of incentive stock options, nonqualified stock options, stock appreciation rights, performance restricted shares, restricted stock awards, and stock awards to officers, directors, and key employees. This is a compensatory arrangement disclosure under Item 5.02(e), material because it establishes the framework for executive and director compensation going forward.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 1.01
The filing discloses entry into a Second Amendment to a Revolving Credit and Security Agreement that increases the maximum facility amount from $400 million to $600 million. While this is a material definitive agreement under Item 1.01, it does not constitute a traditional M&A activity (acquisition, disposition, merger, or change of control), nor does it fit the other specific event categories. The amendment represents a material financing arrangement modification that would affect investor assessment of the company's liquidity and capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-20
Item 8.01
Sally Diffley was appointed Chief Financial Officer of Morgan Stanley Investment Management Inc., the delegated sponsor of the Trust, on May 14, 2026. This is a material executive appointment to a key financial leadership position at the entity responsible for managing the Trust's operations. The disclosure also notes the concurrent resignation of her predecessor, Rohit Goenka, but the principal action disclosed is Diffley's appointment to the CFO role.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-20
Item 1.01
Golden Minerals entered into a Subscription Agreement for a private placement of 3,740,000 common shares at $0.2290 per share, raising approximately $856,463 in gross proceeds under Section 4(a)(2) and Regulation D/S without registration. This unregistered equity issuance materially dilutes existing shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-20
Item 8.01
Golden Minerals' wholly owned subsidiaries (ESM and GMSC) completed the sale of all issued and outstanding shares of Minera William, S.A. de C.V. to Streamline and Horizon Silver Resources Ltd. on May 14, 2026, for US$1,200,000 in cash, including the El Par de Tres 2 property and a 2.0% net smelter returns royalty. This material disposition affects the company's asset base and capital structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-05-20
Item 5.02
J. Carney Hawks was removed from the Board of Directors of Ferrellgas, Inc. on May 18, 2026. Although the removal was not due to disagreement, it represents a departure of a director from the board. The removal was a direct consequence of the conversion of Class B Units to Class A Units on March 16, 2026, which eliminated the Class B holders' right to designate an independent director. Board composition changes are material to investors as they affect governance and oversight.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 1.01
Annovis Bio entered into an Underwriting Agreement on May 20, 2026 to issue 7,895,000 shares of common stock and 7,105,500 warrants in a public offering expected to raise approximately $15 million in gross proceeds, with net proceeds to be used for clinical development and working capital.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 1.01
Gilead entered into an Eleventh Supplemental Indenture on May 20, 2026, governing the issuance of $3 billion in aggregate principal amount of senior notes across four series (2028, 2029, 2031, and 2034 notes) with interest rates ranging from 4.250% to 4.900%. The company intends to use net proceeds for general corporate purposes including potential acquisitions and strategic transactions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
Senseonics held its Annual Meeting of stockholders on May 20, 2026, at which six proposals were submitted to a vote: election of three directors (Goodnow, Kaufman, Larkin), advisory vote on named executive officer compensation, frequency of advisory compensation votes, ratification of KPMG LLP as auditor, approval of an amendment to increase authorized common shares from 70 million to 140 million, and approval of the 2026 Equity Incentive Plan. All proposals passed with disclosed vote tallies and broker non-votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from RLI Corp's May 14, 2026 annual meeting under Item 5.07. The filing reports voting outcomes on three proposals: (1) election of ten directors to one-year terms with detailed vote tallies for each nominee, (2) non-binding advisory approval of named executive officer compensation, and (3) ratification of Deloitte & Touche LLP as independent auditor. The tabular presentation of "For," "Against," "Abstentions," and "Broker Non-Votes" is the standard format for shareholder vote disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 1.01
NanoViricides entered into a Securities Purchase Agreement on May 15, 2026, for a registered direct offering of 1,133,334 shares of common stock at $1.50 per share, along with pre-funded warrants and common warrants, generating approximately $2.0 million in gross proceeds. The offering closed on May 18, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
ProMIS Neurosciences held its Annual Meeting on May 20, 2026, with shareholders voting on three proposals: election of seven directors, ratification of Baker Tilly US, LLP as independent auditor, and approval of an amendment to the 2025 Stock Option and Incentive Plan increasing the share pool by 900,000 Common Shares. Detailed voting results were disclosed for each proposal.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-20
Item 1.01
The Company entered into an underwriting agreement for the issuance and sale of $500 million in 6.250% Notes due 2031. While this is a debt offering rather than a traditional M&A transaction, Item 1.01 covers "entry into a material definitive agreement," and a $500 million debt issuance is material to the registrant's capital structure and financing activities. The ma_activity classification best captures material financing transactions, though this could also be characterized as "other_material" if debt offerings are not considered within the scope of ma_activity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-20
Item 2.02
The filing discloses quarterly financial results for the period ended March 31, 2026 through a press release and supplemental financial information attached as exhibits. This is a standard earnings release disclosure under Item 2.02, which is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses Amendment No. 3 to the Executive Employment Agreement with CEO Brandon Torres Declet, modifying Section 2.6 to establish a new deal completion bonus structure contingent on an IPO, direct listing, or Change in Control. This is a compensatory arrangement modification for a named executive officer, fitting the exec_compensation category. The bonus structure (up to 1.5% of net proceeds or $225,000 minimum) is material to investor assessment of executive incentives and potential dilution in a liquidity event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-05-20
Item 8.01
Skyworks entered into an Agreement and Plan of Merger with Qorvo on October 27, 2025, establishing a two-step merger structure whereby Skyworks' subsidiaries will merge with Qorvo, resulting in Qorvo becoming a wholly owned subsidiary of Skyworks. This is a material acquisition transaction requiring disclosure under Item 1.01 or related M&A provisions, and the filing explicitly states it is being made "in connection with certain transactions related to the Mergers."
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
Redwood Trust entered into an underwriting agreement on May 19, 2026 to sell $125 million in 9.75% senior notes due 2031, with a 30-day over-allotment option for an additional $18.75 million. This is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, but it does not fit neatly into the more specific event categories (it is not M&A, not a dilutive equity issuance, and not a covenant breach or going-concern disclosure). The disclosure is material as it represents a significant financing event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-05-20
Item 1.01
The filing discloses entry into a Merger Agreement on May 17, 2026, whereby InnocsAI LLC will merge into a newly-formed subsidiary of Liminatus Pharma, with the Company acquiring a portfolio of oncology-focused biologic and cellular therapy programs (including CAR-T and antibody candidates). The consideration is 1.6 billion shares at $0.20 per share plus contingent value rights tied to future strategic exits. This is a material acquisition transaction requiring stockholder approval and SEC registration, clearly falling under Item 1.01 (Entry into Material Definitive Agreement) and the ma_activity event type.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-20
Item 7.01
The filing discloses the promotion of two executives—Tamara S. Johnson to Vice President, California Operations and Gregory D. Shimansky to Vice President, Rates and Regulatory Affairs—effective July 1, 2026. These are material appointments to senior officer positions at a regulated utility company where operational and regulatory leadership are critical to investor assessment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from Fifth District Bancorp's Annual Meeting of Stockholders held on May 18, 2026. The filing reports final voting tallies on director elections (Amie L. Lyons and David C. Nolan) and ratification of EisnerAmper LLP as independent auditor, which are standard matters submitted to stockholder votes at annual meetings. This is a material disclosure as it documents the outcome of corporate governance elections.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
Charles Fitzgerald was appointed to the Board of Directors of Chiron Real Estate Inc., effective May 20, 2026. The appointment was disclosed in both Item 5.02 and Item 7.01 (Regulation FD Disclosure via press release), with details regarding his background, committee assignments, and independence determination.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
The 2026 Annual Meeting of stockholders held on May 20, 2026 resulted in approval of four proposals: election of six directors, advisory vote on named executive officer compensation, amendment to the 2016 Equity Incentive Plan (extending term and increasing shares by 300,000), and ratification of Deloitte & Touche LLP as independent auditor. Complete voting tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are disclosed.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-20
Item 8.01
The disclosure announces the commencement of exchange offers and consent solicitations in connection with an anticipated merger transaction in which Qorvo will merge into a Skyworks subsidiary. This constitutes material M&A activity under Item 8.01, as the filing explicitly references "the anticipated transactions pursuant to which Qorvo, Inc. ("Qorvo") will merge with and into a subsidiary of Skyworks" and describes the related debt exchange and consent solicitation mechanics. The merger is a change of control event material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of MacroGenics' 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents voting outcomes for four proposals: election of four Class I directors (all elected), ratification of Ernst & Young LLP as independent auditor (approved), advisory approval of named executive officer compensation (approved), and amendment to the 2023 Equity Incentive Plan to increase available shares by 1,250,000 (approved). The detailed vote tallies for each proposal are the core content of this Item 5.07 disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
The filing discloses two executive appointments: (1) Brian LaRose, the CFO, was appointed principal accounting officer on May 15, 2026, succeeding Leah Putnam; and (2) Tamara Ward was appointed as a director and Chair of the Compensation Committee on the same date. While both are appointments, the principal accounting officer role is a named executive officer position under Item 5.02, making this a material executive appointment. The appointment of a director with committee leadership responsibilities is also material to investors assessing governance and financial oversight.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 8.01
The filing discloses issuance of $997.87 million in Asset Backed Notes on May 20, 2026, with supporting legal opinions from Sidley Austin LLP. While this represents a material financing event for the trust, it does not fit cleanly into the standard M&A or dilutive issuance categories—it is a securitization/ABS issuance by a special-purpose trust vehicle. The disclosure is routine for ABS trusts but material to investors in the notes themselves.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 8.01
CareTrust REIT completed a registered public offering of 12.5 million shares of common stock at $40.225 per share on May 20, 2026, with an additional 1.875 million shares available under an underwriter option. The offering was conducted through a forward sale structure with Wells Fargo and JPMorgan Chase as forward purchasers. This is a material dilutive equity issuance that increases the company's share count and raises capital, disclosed pursuant to an effective S-3 shelf registration statement.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
Trustco Bank Corp N.Y. held its 2026 Annual Meeting of Shareholders on May 19, 2026, with detailed voting results disclosed on four proposals: election of directors, approval of an amendment to the 2019 Equity Incentive Plan increasing available shares by 500,000, an advisory vote on executive compensation, and ratification of Crowe LLP as independent auditor.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-20
Item 5.02
The company's 2019 Equity Incentive Plan was amended to increase the number of shares available for issuance by 500,000 shares (from 700,000 to 1,200,000), a material compensatory arrangement affecting equity grants to officers and directors that was approved by shareholders at the 2026 Annual Meeting.
View raw filing on EDGAR →
8-K
Other material
confidence 50%
filed 2026-05-20
Item 1.01
BD subsidiary issued €600 million in senior unsecured notes with full guarantee from the parent company to refinance existing debt and fund general corporate purposes.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-20
Item 1.01
Cenntro entered into securities purchase agreements for a private placement of 1,000,000 shares of common stock at $3.93 per share for approximately $3.93 million in gross proceeds. The issuance qualifies under Nasdaq Listing Rule 5635(d) as a 20% or greater dilution of outstanding common stock, exempt under Section 4(a)(2) and Regulation S with transfer restrictions and legend requirements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from JetBlue's Annual Meeting of Stockholders held on May 14, 2026. The filing reports voting outcomes on four proposals: election of thirteen directors, advisory vote on executive compensation, ratification of Ernst & Young LLP as independent auditor, and approval of an amendment to the 2020 Crewmember Stock Purchase Plan. All results are presented with vote tallies (FOR, AGAINST, ABSTAIN, and broker non-votes), which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 7.01
The filing discloses James Hardie's fiscal year 2026 Irish Statutory Accounts furnished under Item 7.01 (Regulation FD Disclosure). While this represents audited financial statements that would normally constitute an earnings release, the disclosure is explicitly furnished under Regulation FD rather than filed as a formal earnings announcement (Item 2.02), and the prose emphasizes non-filing status and liability disclaimers. This hybrid treatment—statutory accounts disclosed via FD rather than as a traditional earnings release—does not fit cleanly into the earnings_release category and is best classified as other_material given its materiality to investors assessing the registrant's financial position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-20
Item 2.02
Item 2.02 disclosure of a press release issued on May 20, 2026 regarding Results of Operations and Financial Condition is a standard earnings release disclosure. The filing explicitly references a press release attached as Exhibit 99.1, which is the typical format for quarterly or annual financial results announcements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
Avista Corp. held its 2026 Annual Meeting of Shareholders on May 14, 2026, with voting results on four proposals: election of eleven directors (approved), ratification of Deloitte & Touche LLP as auditor (approved), advisory vote on executive compensation (approved), and an amendment to reduce shareholder approval thresholds from 80% to majority (not approved).
View raw filing on EDGAR →
8-K
Other material
confidence 40%
filed 2026-05-20
Item 1.01
Avista Corp. entered into a material definitive agreement and created a direct financial obligation through the issuance of $160 million in first mortgage bonds ($90 million due 2029 at 4.77% and $70 million due 2056 at 6.10%), with an additional $70 million expected in August 2026, for refinancing and capital expenditure purposes.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 5.03
The filing discloses elimination of an entire class of preferred stock (Series B Preferred Stock) via Certificate of Elimination following redemption of all outstanding shares on May 15, 2026. While this is a corporate governance/capital structure event rather than a specific taxonomy category, the redemption and elimination of a preferred stock class materially affects the registrant's capitalization and is disclosed under Item 5.03. This does not fit cleanly into earnings, executive changes, M&A, impairment, or other more specific event types, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-20
Item 2.02
The filing discloses CorVel Corporation's financial results for the three months and fiscal year ended March 31, 2026, via a press release furnished as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly and annual financial performance information essential to assessing the registrant's financial condition and results of operations.
View raw filing on EDGAR →